| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849183 | American Heart Journal | 2007 | 7 Pages |
Abstract
This is the first randomized, prospective IVUS study demonstrating that pioglitazone reduces neointimal hyperplasia after coronary stenting in nondiabetic patients with MS. Our data suggest that pioglitazone treatment may represent a novel therapeutic tool to target in-stent restenosis in nondiabetic patients with MS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Takuji MD, Hiroto MD, PhD, Ken MD, Norifumi MD, PhD, Takanori MD, PhD, Masatoshi MD, PhD, Muneyasu MD, PhD, Shin-ichi MD, PhD, Masanobu MD, PhD,